Low-Glucose Conditions of Tumor Microenvironment enhance
cytotoxicity of tetrathiomolybdate to neuroblastoma cells

J 2013

Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells

NAVRÁTILOVÁ, Jarmila, Tereza HANKEOVÁ, Petr BENEŠ a Jan ŠMARDA

Základní údaje

Originální název

Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells

Autoři

NAVRÁTILOVÁ, Jarmila (203 Česká republika, domácí), Tereza HANKEOVÁ (203 Česká republika, domácí), Petr BENEŠ (203 Česká republika, domácí) a Jan ŠMARDA (203 Česká republika, garant, domácí)

Vydání

Nutrition and Cancer, 2013, 0163-5581

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10601 Cell biology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.635

Kód RIV

RIV/00216224:14310/13:00065615

Organizační jednotka

Přírodovědecká fakulta

DOI

http://dx.doi.org/10.1080/01635581.2013.789118

UT WoS

000321887700010

Klíčová slova anglicky

tetrathiomolybdate; neuroblastoma; glucose starvation; apoptosis; cancer therapy

Štítky

AKR

Změněno: 19. 2. 2018 10:06, doc. Mgr. Petr Beneš, Ph.D.

Anotace

V originále

Growth of tumor cells depends on sufficient supply of fermentable substrate, such as glucose. This provokes development of new anti-cancer therapies based on dietary restrictions. However, some tumor cells can lower their glucose dependency and activate processes of ATP formation/saving to retain viability even in limited glucose supply. In addition, tumor cells often loose sensitivity to many conventional anti-cancer drugs in the low-glucose conditions. Thus, development of the drugs effectively killing the tumor cells in nutrient-limited conditions is necessary. In this study, we show an enhanced cytotoxicity of tetrathiomolybdate, the drug exhibiting anti-angiogenic and tumor-suppressing effects, to neuroblastoma SH-SY5Y and SK-N-BE(2) cells in the low-glucose conditions. This preference results from the tetrathiomolybdate-induced upregulation of cell dependency on glucose. The cells treated with tetrathiomolybdate increase the uptake of glucose, production of lactate, activate the Akt- and AMPK signaling pathways and down-regulate COX IV. In cells growing in the low-glucose conditions, these events result in significant decrease of the intracellular ATP supply and apoptosis. We propose TM as suitable agent to be used in combination with dietary restrictions in therapy of neuroblastoma.

Návaznosti

CZ.1.07/2.3.00/20.0097, interní kód MU

Název: IntegRECAMO: Intellectual Anchor (Akronym: IntegRECAMO)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, IntegRECAMO: Intellectual Anchor, 2.3 Lidské zdroje ve výzkumu a vývoji

GA301/09/1115, projekt VaV

Název: Úloha proteinů c-Myb a Cox-2 při tvorbě střevních nádorů

Investor: Grantová agentura ČR, Úloha proteinů c-Myb a Cox-2 při tvorbě střevních nádorů

NT13441, projekt VaV

Název: Exprese proteinů rodiny Myb v adenokarcinomech tlustého střeva a vztah k jejich metastatickému potenciálu

Citovat

NAVRÁTILOVÁ, Jarmila, Tereza HANKEOVÁ, Petr BENEŠ a Jan ŠMARDA. Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells. Nutrition and Cancer. 2013, roč. 65, č. 5, s. 702-710. ISSN 0163-5581. Dostupné z: https://dx.doi.org/10.1080/01635581.2013.789118.

@article{1116067,
   author = {Navrátilová, Jarmila and Hankeová, Tereza and Beneš, Petr and Šmarda, Jan},
   article_number = {5},
   doi = {http://dx.doi.org/10.1080/01635581.2013.789118},
   keywords = {tetrathiomolybdate; neuroblastoma; glucose starvation; apoptosis; cancer therapy},
   language = {eng},
   issn = {0163-5581},
   journal = {Nutrition and Cancer},
   title = {Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells},
   volume = {65},
   year = {2013}
}

TY  - JOUR
ID  - 1116067
AU  - Navrátilová, Jarmila - Hankeová, Tereza - Beneš, Petr - Šmarda, Jan
PY  - 2013
TI  - Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells
JF  - Nutrition and Cancer
VL  - 65
IS  - 5
SP  - 702-710
EP  - 702-710
SN  - 01635581
KW  - tetrathiomolybdate
KW  - neuroblastoma
KW  - glucose starvation
KW  - apoptosis
KW  - cancer therapy
N2  - Growth of tumor cells depends on sufficient supply of fermentable substrate, such as glucose. This provokes development of new anti-cancer therapies based on dietary restrictions. However, some tumor cells can lower their glucose dependency and activate processes of ATP formation/saving to retain viability even in limited glucose supply. In addition, tumor cells often loose sensitivity to many conventional anti-cancer drugs in the low-glucose conditions. Thus, development of the drugs effectively killing the tumor cells in nutrient-limited conditions is necessary. In this study, we show an enhanced cytotoxicity of tetrathiomolybdate, the drug exhibiting anti-angiogenic and tumor-suppressing effects, to neuroblastoma SH-SY5Y and SK-N-BE(2) cells in the low-glucose conditions. This preference results from the tetrathiomolybdate-induced upregulation of cell dependency on glucose. The cells treated with tetrathiomolybdate increase the uptake of glucose, production of lactate, activate the Akt- and AMPK signaling pathways and down-regulate COX IV. In cells growing in the low-glucose conditions, these events result in significant decrease of the intracellular ATP supply and apoptosis. We propose TM as suitable agent to be used in combination with dietary restrictions in therapy of neuroblastoma.
ER  -

NAVRÁTILOVÁ, Jarmila, Tereza HANKEOVÁ, Petr BENEŠ a Jan ŠMARDA. Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells. \textit{Nutrition and Cancer}. 2013, roč.~65, č.~5, s.~702-710. ISSN~0163-5581. Dostupné z: https://dx.doi.org/10.1080/01635581.2013.789118.

Podrobný výpis o publikaci